Your browser doesn't support javascript.
loading
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals.
Cockerham, Leslie R; Yukl, Steven A; Harvill, Kara; Somsouk, Ma; Joshi, Sunil K; Sinclair, Elizabeth; Liegler, Teri; Hoh, Rebecca; Lyons, Sophie; Hunt, Peter W; Rupert, Adam; Sereti, Irini; Morcock, David R; Rhodes, Ajantha; Emson, Claire; Hellerstein, Marc K; Estes, Jacob D; Lewin, Sharon; Deeks, Steven G; Hatano, Hiroyu.
Afiliación
  • Cockerham LR; Division of Infectious Diseases, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Yukl SA; Department of Medicine, San Francisco VA Medical Center, and University of California, San Francisco (UCSF), San Francisco, California.
  • Harvill K; HIV, Infectious Diseases, and Global Medicine Division, San Francisco General Hospital, University of California, San Francisco, California.
  • Somsouk M; Division of Gastroenterology, San Francisco General Hospital, University of California, San Francisco, California.
  • Joshi SK; Department of Medicine, San Francisco VA Medical Center, and University of California, San Francisco (UCSF), San Francisco, California.
  • Sinclair E; HIV, Infectious Diseases, and Global Medicine Division, San Francisco General Hospital, University of California, San Francisco, California.
  • Liegler T; HIV, Infectious Diseases, and Global Medicine Division, San Francisco General Hospital, University of California, San Francisco, California.
  • Hoh R; HIV, Infectious Diseases, and Global Medicine Division, San Francisco General Hospital, University of California, San Francisco, California.
  • Lyons S; HIV, Infectious Diseases, and Global Medicine Division, San Francisco General Hospital, University of California, San Francisco, California.
  • Hunt PW; HIV, Infectious Diseases, and Global Medicine Division, San Francisco General Hospital, University of California, San Francisco, California.
  • Rupert A; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Sereti I; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • Morcock DR; Frederick National Laboratory, Leidos Biomedical Research, Frederick, Maryland.
  • Rhodes A; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
  • Emson C; Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
  • Hellerstein MK; Kinemed, Inc., Emeryville, California.
  • Estes JD; Kinemed, Inc., Emeryville, California.
  • Lewin S; Department of Nutritional Science and Toxicology, University of California, Berkeley, California.
  • Deeks SG; Frederick National Laboratory, Leidos Biomedical Research, Frederick, Maryland.
  • Hatano H; Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Pathog Immun ; 2(3): 310-334, 2017.
Article en En | MEDLINE | ID: mdl-28936485
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Pathog Immun Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Pathog Immun Año: 2017 Tipo del documento: Article